RAPALIMUS TABLETS 1MG

RAPALIMUS TABLETS 1MG

RAPALIMUS TABLETS 1MG, also known in Japanese as ラパリムス錠 1mg, is an oral prescription medicine containing sirolimus 1mg. Sirolimus, also widely known in research literature as rapamycin, is an mTOR inhibitor used under professional medical supervision.

RAPALIMUS TABLETS 1MG is manufactured and marketed in Japan by Nobelpharma Co., Ltd. / ノーベルファーマ株式会社. Each tablet contains 1mg of sirolimus. The product is supplied as tablets for oral administration and is intended for prescription medical use only.

Product Information

• Product Name: RAPALIMUS TABLETS 1MG
• Japanese Name: ラパリムス錠 1mg
• Generic Name: Sirolimus Tablets 1mg
• Research Name: Rapamycin Tablets 1mg
• Chinese Name: 雷帕立慕斯錠 1mg / 西羅莫司片 1mg
• Active Ingredient: Sirolimus
• Japanese Ingredient: シロリムス
• Strength: 1mg per tablet
• Package Size: 30 tablets
• Dosage Form: Tablet
• Route: Oral
• Drug Class: mTOR inhibitor / immunosuppressive agent
• Manufacturer: Nobelpharma Co., Ltd.
• Japanese Manufacturer: ノーベルファーマ株式会社
• Use Level: Prescription medicine / professional medical supervision required

What Is RAPALIMUS TABLETS 1MG?

RAPALIMUS TABLETS 1MG contains sirolimus, an mTOR inhibitor. The mTOR pathway is involved in cell growth, proliferation, metabolism, and immune regulation. By inhibiting mTOR signaling, sirolimus can modulate immune and cellular activity in specific medical conditions.

In Japan, ラパリムス錠 1mg is associated with specialist medical treatment areas such as lymphangioleiomyomatosis and certain refractory vascular or lymphatic diseases. Treatment should always be directed by a qualified healthcare professional, with appropriate monitoring of clinical response, safety, and blood concentration when required.

Key Benefits

• Contains sirolimus 1mg per tablet
• mTOR inhibitor with immunomodulating activity
• Used under specialist medical supervision
• Associated with treatment of lymphangioleiomyomatosis
• Associated with treatment of certain refractory lymphatic or vascular diseases
• Oral tablet format
• Manufactured by Nobelpharma Co., Ltd. in Japan
• Prescription-use medicine requiring clinical monitoring

Indications and Uses

This product is generally associated with professional medical treatment for:

• Lymphangioleiomyomatosis, also known as LAM
• Refractory lymphatic diseases
• Lymphangioma / lymphatic vascular malformation
• Lymphangiomatosis
• Gorham disease
• Lymphangiectasia
• Refractory vascular tumors and vascular malformations, where clinically appropriate
• Specialist immunomodulatory treatment under medical supervision

Use must follow the official prescribing information, physician assessment, patient condition, and applicable local regulations. This product should not be used for self-medication.

Research and Anti-Aging Interest

Sirolimus / rapamycin has attracted scientific and public attention because of its role in the mTOR pathway, a pathway involved in metabolism, cellular growth, and aging-related research. It has also been discussed in longevity-related media and documentaries, including public interest around biohacking and longevity figures.

However, anti-aging or longevity use is not the same as an approved medical indication. This product should not be presented as a guaranteed anti-aging medicine, longevity supplement, beauty product, or wellness supplement. Any off-label consideration must be discussed with a qualified healthcare professional.

Dosage and Administration

• This product is taken orally.
• Use only as prescribed by a qualified healthcare professional.
• Dosage depends on the patient’s diagnosis, body surface area, clinical condition, treatment response, and blood trough concentration where applicable.
• For lymphangioleiomyomatosis, a commonly referenced adult dosage is sirolimus 2mg once daily, adjusted according to patient condition, with a maximum of 4mg once daily.
• For refractory lymphatic disease, the starting dose may vary according to body surface area, with subsequent adjustment based on blood trough concentration and clinical response.
• Take consistently at the same time each day unless otherwise directed by a healthcare provider.
• Do not start, stop, increase, reduce, or change the dosing schedule without medical advice.

Important Use Clarification

RAPALIMUS TABLETS 1MG is a prescription mTOR inhibitor medicine. It is not a dietary supplement, not a general anti-aging supplement, not a cosmetic medicine, not a skin booster, not a dermal filler, not a water-light injection, and not a weight management product.

Precautions

• Prescription medicine; use only under medical supervision.
• Not suitable for self-medication or unsupervised longevity use.
• Do not use if allergic to sirolimus, rapamycin, or any component of the product.
• Use caution in patients with liver dysfunction, infection, lung disease, kidney problems, abnormal lipid levels, diabetes, poor wound healing, or immunocompromised conditions.
• May increase susceptibility to infections due to immunosuppressive effects.
• Vaccination plans should be discussed with a healthcare provider.
• Pregnant or breastfeeding individuals should consult a healthcare provider before use.
• Regular blood tests and clinical monitoring may be required.
• Blood trough concentration monitoring may be required depending on indication and physician instructions.
• Inform your healthcare provider about all medicines, supplements, and herbal products before use.

Possible Side Effects

Possible side effects may include:

• Mouth ulcers or stomatitis
• Rash or acne-like skin symptoms
• Diarrhea
• Nausea or gastrointestinal discomfort
• Headache
• Swelling or edema
• Increased blood lipid levels
• Delayed wound healing
• Increased risk of infection
• Abnormal blood test results

Serious but less common risks may include severe infection, interstitial lung disease or lung inflammation, kidney-related problems, liver function abnormalities, severe allergic reaction, blood disorders, or serious metabolic abnormalities. Seek medical attention immediately if symptoms such as fever, persistent cough, shortness of breath, chest pain, severe rash, unusual bleeding, severe mouth ulcers, swelling, or signs of infection occur.

Drug Interactions

Sirolimus may interact with various medicines and substances. Patients should inform their healthcare provider about all prescription medicines, over-the-counter medicines, supplements, herbal products, and dietary habits. Some medicines may increase or decrease sirolimus blood levels, affecting safety and effectiveness.

Do not combine with other medicines or supplements without professional advice.

Storage

• Store according to the official product packaging or prescribing information.
• Keep away from direct sunlight, heat, and moisture.
• Store in the original package until use.
• Keep out of reach of children.
• Do not use after the expiry date printed on the packaging.

Package Contents

• RAPALIMUS TABLETS 1MG
• 30 tablets per box
• Each tablet contains sirolimus 1mg

Important Disclaimer

This product information is provided for general product reference and SEO description purposes only. It does not replace professional medical advice, diagnosis, treatment, official prescribing information, or product labeling. RAPALIMUS TABLETS 1MG should be used only under the supervision of a qualified healthcare professional according to applicable medical standards and local regulations.